INNATE IMMUNOTHERAPEUTICS LTD's ticker is and the CUSIP is BHBX6X900.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,000 | -10.0% | 45,000 | -90.0% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | +100.0% | 450,000 | +125.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | 0.0% | 200,000 | +100.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | -91.4% | 100,000 | 0.0% | 0.00% | -85.7% |
| Q1 2017 | $58,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|